Immunic Inc. (IMUX) Announces Proposed Common Share Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to Immunic Inc. (IMUX) Announces Proposed Common Share Offering

Immunic Inc. (IMUX) Prices 2.18M Share Common Stock Offering at $11.40/Each

June 10, 2020 9:18 AM EDT

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the pricing of its previously announced public offering for the offering of 2,175,000 shares of common... More

Immunic Inc. (IMUX) Reports FDA Allowance to Begin Phase 2, CALVID-1 Clinical Trial of IMU-838 in COVID-19

June 9, 2020 7:04 AM EDT

Immunic, Inc. (NASDAQ: IMUX) today announced receipt of regulatory allowance from the U.S. Food and Drug Administration (FDA) to initiate its phase 2, CALVID-1 clinical trial of IMU-838, the company's selective oral DHODH inhibitor, in coronavirus disease 2019 (COVID-19) at centers in the United... More